Anais Reinoso-Jimenez

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Generation and functional evaluation of STAb-T cells.

Generation and functional evaluation of STAb-T cells.

Journal: Methods in cell biology

Published: January 31, 2026

A Drug-Gated, Modular STAb-T Immunotherapy With External Control.

A Drug-Gated, Modular STAb-T Immunotherapy With External Control.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: January 22, 2026

CD22 CAR-T cells secreting CD19 T-cell engagers for improved control of B-cell acute lymphoblastic leukemia progression.

CD22 CAR-T cells secreting CD19 T-cell engagers for improved control of B-cell acute lymphoblastic leukemia progression.

Journal: Journal for immunotherapy of cancer

Published: April 07, 2025

CD4+ tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenografts.

CD4+ tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenografts.

Journal: Oncoimmunology

Published: August 29, 2024

Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses.

Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses.

Journal: Oncoimmunology

Published: April 16, 2024

Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo.

Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo.

Journal: Science translational medicine

Published: February 14, 2024

Exploiting FcRn engagement of an albumin-CpG oligonucleotide covalent conjugate for potent TLR9 immune induction.

Exploiting FcRn engagement of an albumin-CpG oligonucleotide covalent conjugate for potent TLR9 immune induction.

Journal: The Journal of biological chemistry

Published: January 27, 2024

Efficient preclinical treatment of cortical T cell acute lymphoblastic leukemia with T lymphocytes secreting anti-CD1a T cell engagers.

Efficient preclinical treatment of cortical T cell acute lymphoblastic leukemia with T lymphocytes secreting anti-CD1a T cell engagers.

Journal: Journal for immunotherapy of cancer

Published: October 19, 2022

T-cell receptor signaling in Schimke immuno-osseous dysplasia is SMARCAL1-independent.

T-cell receptor signaling in Schimke immuno-osseous dysplasia is SMARCAL1-independent.

Journal: Frontiers in immunology

Published: June 27, 2022

Tumor targeted 4-1BB agonist antibody-albumin fusions with high affinity to FcRn induce anti-tumor immunity without toxicity.

Tumor targeted 4-1BB agonist antibody-albumin fusions with high affinity to FcRn induce anti-tumor immunity without toxicity.

Journal: iScience

Published: February 04, 2022

Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers.

Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers.

Journal: Cancer immunology research

Published: October 07, 2021

CD3G or CD3D Knockdown in Mature, but Not Immature, T Lymphocytes Similarly Cripples the Human TCRαβ Complex.

CD3G or CD3D Knockdown in Mature, but Not Immature, T Lymphocytes Similarly Cripples the Human TCRαβ Complex.

Journal: Frontiers in cell and developmental biology

Published: September 20, 2020

Showing 1-12 of 22

Last Updated: 09/26/2026